Lebanese Interhospital Pneumococcal Surveillance Program
Key facts
- Who runs it
- American University of Beirut Medical Center
- Where
- Lebanon1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 700 people, planned
- Started
- Oct 2005
- Expected to end
- Oct 2030
- Type of study
- Observational
- Record updated
- 3 February 2023
Who can take part
- Age
- 1 day and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Samples included in the study are those that are:; culture proven; invasive pneumococcal infections; in patients of all ages admitted to different hospitals all over Lebanon
- Acceptable samples include:; positive isolates from blood; cerebrospinal fluid; other normally sterile body sites such as empyema fluid, abscesses, joint fluid, middle ear fluid obtained by tympanocentesis in the operating room, and lung needle aspiration
Who cannot take part
- non S. pneumoniae isolates
This trial is currently available in Lebanon.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Streptococcus pneumoniae (pneumococcus) is a bacterium that causes severe infections in children and adults such as meningitis, pneumonia, and blood stream infection. There are many types of these bacteria defined by the type of sugar coat that they have. These are classified as serotypes. There are common serotypes that cause severe disease and are preventable by vaccination of children. Other less common types are more difficult to prevent. The investigators aim to determine the serotypes that cause invasive pneumococcal disease in Lebanon and to study their sensitivity to different antibiotics. The investigators will collect bacterial isolates from different hospitals in Lebanon isolated from the blood or spinal fluid of patients with invasive pneumococcal disease. This information will help the investigators determine the usefulness of available pneumococcal vaccines in preventing these infections. The data will be distributed to all primary care physicians treating children in Lebanon and will be shared with the Ministry of Health.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Lebanese Interhospital Pneumococcal Surveillance Program (LIPSP)
- Record updated
- 3 February 2023